Variant report
Variant | esv1800961 |
---|---|
Chromosome Location | chr4:95026709-95039877 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HPGDS-1 | chr4:95038943-95039252 | ENSG00000246541 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF689 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560890218 | chr4:95035247-95035248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529836967 | chr4:95035277-95035278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549593914 | chr4:95035280-95035281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562826809 | chr4:95035297-95035298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76911419 | chr4:95035345-95035346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112051203 | chr4:95035402-95035403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371918960 | chr4:95035465-95035466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79313542 | chr4:95035511-95035512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534226347 | chr4:95035528-95035529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184082852 | chr4:95035584-95035585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567985641 | chr4:95035635-95035636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536824628 | chr4:95035644-95035645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5860356 | chr4:95035651-95035652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs33953705 | chr4:95035652-95035653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3066138 | chr4:95035654-95035655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556731675 | chr4:95035718-95035719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs5019896 | chr4:95035751-95035752 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs17373678 | chr4:95035771-95035772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115072497 | chr4:95035787-95035788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10023582 | chr4:95035811-95035812 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs115904272 | chr4:95035833-95035834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371786483 | chr4:95035835-95035836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141353949 | chr4:95035850-95035851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545749933 | chr4:95035871-95035872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574426953 | chr4:95035963-95035964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187772985 | chr4:95035983-95035984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540653159 | chr4:95036039-95036040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115902474 | chr4:95036083-95036084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563500008 | chr4:95036121-95036122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76636971 | chr4:95036185-95036186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200038381 | chr4:95036186-95036187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75906325 | chr4:95036187-95036188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76562577 | chr4:95036188-95036189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs397994563 | chr4:95036203-95036204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150356641 | chr4:95036210-95036211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191924502 | chr4:95036234-95036235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112703142 | chr4:95036263-95036264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564241922 | chr4:95036268-95036269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138077259 | chr4:95036377-95036378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149547899 | chr4:95036381-95036382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552730018 | chr4:95036394-95036395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569397724 | chr4:95036415-95036416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567924212 | chr4:95036420-95036421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530441279 | chr4:95036464-95036465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184392398 | chr4:95036489-95036490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117054400 | chr4:95036500-95036501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186903679 | chr4:95036548-95036549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1472984 | chr4:95036553-95036554 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs35568170 | chr4:95036564-95036565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76972311 | chr4:95036578-95036579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Sinonasal adenocarcinoma | 21360264 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:95035200-95039000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:95036600-95037200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:95037800-95038800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr4:95038000-95038800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr4:95038000-95039000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr4:95038000-95039000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr4:95038000-95039200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr4:95038200-95039000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr4:95038400-95039400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr4:95038600-95038800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr4:95038800-95042200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |